Oncology

Back to articles

Genetics affect tamoxifen outcomes

KEY POINT

Variants in the cytochrome P450 2D6 gene (CYP2D6) affect outcomes in women with early-stage, hormone receptor–positive breast cancer treated with adjuvant tamoxifen therapy, according to a recent study published in JAMA.